These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8186065)

  • 21. Pharmacokinetics of cefuroxime and ceftazidime in patients with acute renal failure treated by continuous arteriovenous haemodialysis.
    Davies SP; Lacey LF; Kox WJ; Brown EA
    Nephrol Dial Transplant; 1991; 6(12):971-6. PubMed ID: 1798597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interactions of cefprozil with food, propantheline, metoclopramide, and probenecid in healthy volunteers.
    Shukla UA; Pittman KA; Barbhaiya RH
    J Clin Pharmacol; 1992 Aug; 32(8):725-31. PubMed ID: 1487562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal tubular secretion and reabsorption as factors in ochratoxicosis: effects of probenecid on nephrotoxicity.
    Stein AF; Phillips TD; Kubena LF; Harvey RB
    J Toxicol Environ Health; 1985; 16(3-4):593-605. PubMed ID: 4087321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.
    Hedaya MA; Sawchuk RJ
    J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a postsecretory reabsorptive site for uric acid in man.
    Diamond HS; Paolino JS
    J Clin Invest; 1973 Jun; 52(6):1491-9. PubMed ID: 4703233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.
    Russel FG; Wouterse AC; Van Ginneken CA
    Biopharm Drug Dispos; 1989; 10(2):137-52. PubMed ID: 2706315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers.
    Inotsume N; Nishimura M; Nakano M; Fujiyama S; Sato T
    J Clin Pharmacol; 1990 Jan; 30(1):50-6. PubMed ID: 2303581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible active tubular secretion of sulfamonomethoxine and its metabolites in pigs.
    Shimoda M; Aihara E; Koyanagi M; Kokue E; Hayama T
    J Pharmacobiodyn; 1986 Mar; 9(3):229-33. PubMed ID: 3723317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
    Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
    Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A physiologically based kidney model for the renal clearance of ranitidine and the interaction with cimetidine and probenecid in the dog.
    Boom SP; Meyer I; Wouterse AC; Russel FG
    Biopharm Drug Dispos; 1998 Apr; 19(3):199-208. PubMed ID: 9570004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of three methods of antibiotic prophylaxis in knee arthroplasty.
    Field J; Webb J; Bannister GC; Lovering AM; Reeves DS
    J Arthroplasty; 1992 Mar; 7(1):17-9. PubMed ID: 1564460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous kinetic modelling of plasma levels and urinary excretion of salicyluric acid, and the influence of probenecid.
    Hekman P; van Ginneken CA
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):239-49. PubMed ID: 6653616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration of cefuroxime and ceftazidime into human lungs.
    Perea EJ; Ayarra J; García Iglesias MC; García Luque I; Loscertales J
    Chemotherapy; 1988; 34(1):1-7. PubMed ID: 3280266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis.
    Local FK; Munro AJ; Kerr DN; Sussman M
    Clin Nephrol; 1981 Jul; 16(1):40-3. PubMed ID: 7273495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologically based pharmacokinetic model for the renal clearance of phenolsulfonphthalein and the interaction with probenecid and salicyluric acid in the dog.
    Russel FG; Wouterse AC; van Ginneken CA
    J Pharmacokinet Biopharm; 1987 Aug; 15(4):349-68. PubMed ID: 3681664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of probenecid on the pharmacokinetics and pharmacodynamics of procainamide.
    Lam YW; Boyd RA; Chin SK; Chang D; Giacomini KM
    J Clin Pharmacol; 1991 May; 31(5):429-32. PubMed ID: 2050827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis.
    La Greca G; Biasioli S; Chiaramonte S; Fabris A; Feriani M; Pisani E; Ronco C; Xerri L
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):92-4. PubMed ID: 7061184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal handling of phenol red. III. Bidirectional transport.
    Gerdes U; Kristensen J; Møller JV; Sheikh MI
    J Physiol; 1978 Apr; 277():115-29. PubMed ID: 650511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-dependence of renal tubular reabsorption of nitrofurantoin.
    Bräunlich H; Bonow A; Schröter S
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):92-101. PubMed ID: 27154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.